All 450 participants starting from adults down to 6 months young infants are enrolled in our study in Bangladesh

One and a half year ago a phase I/II randomized, double-blind, placebo-controlled trial was started in Dhaka, Bangladesh. All 450 participants have now been enrolled and the last child received the vaccine this February. This clinical trial is the first important step toward showing that our vaccine can protect children in the developing world against […]